Risks and Benefits of Thrombolytic, Antiplatelet, and Anticoagulant Therapies for ST Segment Elevation Myocardial Infarction: Systematic Review

Figure 2

Correlation between number of classes of drugs and (a) mortality (𝑟=−0.466, 𝑃=0.005) and between number of classes of drugs and (b) major bleeding (𝑟=0.403, 𝑃=0.016).

(a)

(b)